Search clinical trials for: 18F-Florbetaben PET/CT

Total 628 results

National University of Ireland, Galway, Ireland

Suspended

Coronavirus (COVID-19) ACEi/ARB Investigation (CORONACION)

COVID-19 | Hypertension

Ireland
Memorial Sloan Kettering Cancer Center

Completed

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Ovarian Cancer

United States
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
Memorial Sloan Kettering Cancer Center

No longer available

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Recurrent Prostate Cancer | Prostate Cancer

United States
Medical University of Graz

Completed

TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer (TOF-P)

Pancreatic Cancer | Pancreatitis | IPMN
Assiut University

Unknown

The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients

Lung Cancer
Institut Jerome Lejeune
Central Hospital, Nancy, France; Hôpital Cochin

Completed

Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children (ACTHYF)

Down Syndrome

France
University of Texas Southwestern Medical Center

Withdrawn

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Breast Cancer

United States
Johns Hopkins University

Completed

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Melanoma | Sarcoma | Lymphoma | Carcinoma | Myeloma

United States
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Prognostic PET/CT Model in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

France
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

PET/CT-Assessment of Liver Tumor Ablation

Liver Neoplasms | Liver Tumor

United States
University of California, San Francisco
Genentech, Inc.

Terminated

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Esophageal Cancer

United States
Yerevan State Medical University
Servier

Unknown

Effect of Atorvastatin on Carotid Intima Media Thickness

Hypercholesterolemia | Essential Hypertension
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Wuerzburg University Hospital

Completed

Modern Hybrid Imaging in Patients With OSCC (PETOSCC)

Neoplasm

Germany
Abramson Cancer Center of the University of Pennsylvania

Completed

F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer

Brain Metastases From Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline

Unknown

Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation (VERIFY)

Sarcoidosis | Lung Inflammation

United Kingdom
Sidney Kimmel Cancer Center at Thomas Jefferson...

Terminated

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

Oral Cavity Squamous Cell Carcinoma
National Cancer Institute (NCI)

Withdrawn

[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

Kidney Neoplasms
National Institute of Allergy and Infectious Diseases...

Withdrawn

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

Lymphoma | Autoimmune Lymphoproliferative Syndrome
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Ovarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
University of Wisconsin, Madison

Completed

PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404

Glioblastoma Multiforme | Brain Metastases

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

PET/CT Imaging of Malignant Brain Tumors With 124I-NM404

Glioblastoma | Brain Metastases

United States
National Taiwan University Hospital

Unknown

18F-FSPG PET/CT Imaging in Patients With Cancers

Breast Neoplasms | Abdominal Cancer | Pulmonary Cancer

Taiwan
GlaxoSmithKline
Quintiles, Inc.

Completed

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Autoimmune Diseases

United Kingdom
University of California, San Francisco
CellSight Technologies, Inc.

Withdrawn

T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

Non-small Cell Lung Cancer
Rigshospitalet, Denmark

Terminated

uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Bone Metastases | Prostate Cancer Metastatic

Denmark
Turku University Hospital

Completed

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

Finland
Jiang Wu

Terminated

Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

Breast Cancer

China
Memorial Sloan Kettering Cancer Center

Withdrawn

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Histologically-confirmed Malignancies

United States
Cambridge University Hospitals NHS Foundation Trust
AstraZeneca

Completed

Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy (CaNCaP03)

Prostate Cancer

United Kingdom
James J. Peters Veterans Affairs Medical Center

Unknown

CTCL Directed Therapy

Lymphoma, T-Cell, Cutaneous

United States
First Affiliated Hospital Xi'an Jiaotong University

Unknown

Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension

Hypertension

China
mAbxience Research S.L.
Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA

Completed

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Metastatic Colorectal Cancer (mCRC)

Argentina, Brazil, India, Spain, Ukraine
Washington University School of Medicine

Terminated

18F-FLT PET Imaging in Patients With Advanced Melanoma

Melanoma

United States
Stanford University

Completed

PET/MRI Evaluation of Cardiac Amyloid

Cardiac Amyloidosis

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Institutes of Health (NIH)

Completed

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

Prostate Cancer

United States
Pfizer

Completed

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

Follicular Lymphoma

United States, Spain, United Kingdom, Korea, Republic of, France, Portugal, India, Mexico, Switzerland, Japan, Germany, Romania, Greece, Austria, Belgium, Italy, Thailand, Croatia, Philippines, Russian Federation, Puerto Rico, Ukr... and more
St. Louis University
Lucerno Dynamics Limited Liability Company (LLC)

Completed

Patterns and Prevalence of FDG Extravasation in PET/CT Scans (Lucerno device)

Intravenous Infiltration

United States
Pulmonary Hospital Zakopane

Completed

Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC.

Non-small Cell Lung Cancer

Poland
University of California, Davis

Completed

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone (PETCT)

Normal Subjects

United States
Central Hospital, Nancy, France

Completed

18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study (MAF)

Amyloid PET Imaging

France
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
GE Healthcare

Completed

Clinical Evaluation of an Integrated PET/MRI System (PET/MR_ZURICH)

Subjects With Clinical Indication for PET/CT

Switzerland
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer

Esophageal Cancer

China
Second Affiliated Hospital of Wenzhou Medical University
Beijing Chao Yang Hospital; General Hospital of Ningxia Medical University; First... and other collaborators

Unknown

PET/CT Based Radiomics for Lung Cancer (PERL)

Lung Cancer

China
Spine Centre of Southern Denmark
Odense University Hospital

Completed

Quantitative Sensory Testing and PET/CT Scanning in Assessment of Surgical Outcome for Lumbar Disc Herniation (PET-Pain)

Lumbar Disc Herniation | Radiculopathy Lumbar

Search clinical trials for: 18F-Florbetaben PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations